With US now in hand, BioNTech CEO looks for more vaccine production
NEW YORK (Reuters) - The chief executive of Germany's BioNTech SE said the biggest challenge facing it and partner Pfizer Inc now that their COVID-19 vaccine is authorized for use…
NEW YORK (Reuters) - The chief executive of Germany's BioNTech SE said the biggest challenge facing it and partner Pfizer Inc now that their COVID-19 vaccine is authorized for use…